Stocks
NeoGenomics Projects $797M-$803M 2026 Revenue
NeoGenomics forecasts significant revenue growth for 2026, projecting between $797 million and $803 million, boosted by the PanTracer Liquid MolDX approval.
#revenue 2 articles
Stocks
Stantec Reports C$5.5B in Sustainability-Driven Revenue
Stantec's 19th annual Sustainability Report reveals C$5.5 billion in revenue from projects aligned with UN Sustainable Development Goals, representing 68% of its...